SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-3
Document Type: S-3
Date Filed: 2025-11-26
Accession Number: 0001213900-25-115554
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025115554/ea0266812-s3_synergy.htm

Chunk 15 of 26
Word Count: 1450
Character Count: 9551

Document Content:

the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. You should assume that the information contained in this prospectus supplement is accurate only as of their respective dates and that any information we have incorporated by reference is accurate only as of the date of the document incorporated by reference, regardless of the time of delivery of this prospective supplement for any sale of securities. ABOUT THIS PROSPECTUS SUPPLEMENT This prospectus supplement is part of a registration statement that we filed with the Securities and Exchange Commission, or SEC, utilizing a shelf registration process. Under the shelf registration process, we may offer shares of our common stock having an aggregate offering price of up to $100 million from time to time under this prospectus supplement at prices and on terms to be determined by market conditions at the time of offering.

This prospectus supplement
describes the specific terms of the common stock we are offering and also adds to, and updates information contained in the documents
incorporated by reference into this prospectus supplement. To the extent there is a conflict between the information contained in this
prospectus supplement, on the one hand, and the information contained in any document incorporated by reference into this prospectus supplement
that was filed with the SEC before the date of this prospectus supplement, on the other hand, you should rely on the information in this
prospectus supplement. If any statement in one of these documents is inconsistent with a statement in another document having a later
date —for example, a document incorporated by reference into this prospectus supplement —the statement in the document having
the later date modifies or supersedes the earlier statement.

You should rely only on the
information contained in, or incorporated by reference into this prospectus supplement and in any free writing prospectus that we may
authorize for use in connection with this offering. We have not, and the sales agents have not, authorized any other person to provide
you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not,
and the sales agents are not, making an offer to sell or soliciting an offer to buy our securities in any jurisdiction in which an offer
or solicitation is not authorized or in which the person making that offer or solicitation is not qualified to do so or to anyone to whom
it is unlawful to make an offer or solicitation. You should assume that the information appearing in this prospectus supplement, the documents
incorporated by reference into this prospectus, and in any free writing prospectus that we may authorize for use in connection with this
offering, is accurate only as of the date of those respective documents. Our business, financial condition, results of operations and
prospects may have changed since those dates. You should read this prospectus supplement, the documents incorporated by reference into
this prospectus supplement, and any free writing prospectus that we may authorize for use in connection with this offering, in their entirety
before making an investment decision. You should also read and consider the information in the documents to which we have referred you
in the sections of this prospectus supplement entitled “Where You Can Find More Information” and “Incorporation by Reference.”

We are offering to sell, and
seeking offers to buy, shares of common stock only in jurisdictions where offers and sales are permitted. The distribution of this prospectus
supplement and the offering of the common stock in certain jurisdictions may be restricted by law. Persons outside the United States who
come into possession of this prospectus supplement must inform themselves about, and observe any restrictions relating to, the offering
of the common stock and the distribution of this prospectus supplement outside the United States. This prospectus supplement does not
constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities offered by
this prospectus supplement by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation.

We further note that the representations,
warranties and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference into
the prospectus and accompanying prospectus were made solely for the benefit of the parties to such agreement, including, in some cases,
for the purpose of allocating risk among the parties to such agreement, and should not be deemed to be a representation, warranty or covenant
to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations,
warranties and covenants should not be relied on as accurately representing the current state of our affairs.

Unless otherwise stated, all
references to “us,” “our,” “Synergy,” “we,” the “Company” and similar designations
refer to Synergy CHC Corp. and its subsidiaries. Our logo, trademarks and service marks are the property of Synergy CHC Corp. and its
consolidated subsidiaries. Other trademarks or service marks appearing in this prospectus supplement are the property of their respective
holders.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This prospectus supplement
and the documents incorporated by reference herein contains forward-looking statements that reflect our current expectations and views
of future events. The forward-looking statements are contained principally in the sections included or incorporated by reference herein
entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Readers are cautioned that known and unknown risks, uncertainties and other factors, including those over which we may have no control
and others listed in the “Risk Factors” section of this prospectus supplement, may cause our actual results, performance or
achievements to be materially different from those expressed or implied by the forward-looking statements.

You can identify some of
these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,”
“aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,”
“potential,” “continue” or other similar expressions. We have based these forward-looking statements largely
on our current expectations and projections about future events that we believe may affect our financial condition, results of operations,
business strategy and financial needs. These forward-looking statements include statements relating to:

●	our ability to compete in our industry, including against competitors
that have significantly greater financial, technical and marketing resources than we do;

●	our ability to respond to customer preferences and successfully
develop new and innovative products in a timely manner and effectively manage the introduction of new or enhanced products;

●	risks related to a loss of, or material cancellation, reduction,
or delay in purchases by, one or more of our largest customers;

●	our outside suppliers and manufacturers failing to supply products
in sufficient quantities and in a timely fashion;

●	our ability to execute on our strategic initiatives (including
acquisitions);

●	our ability to maintain the reputation of our brands;

●	the risks related to consumers’ perception of the safety
and quality of our products as well as similar products distributed by other companies in our industry;

●	the risks related to third parties asserting intellectual property
infringement claims against us;

●	the risks related to our planned expansion into additional international
markets;

●	the risks related to adverse economic conditions;

●	the risks related to catastrophic events;

●	our ability to retain key personnel, manage our business effectively,
and continue to grow;

●	the impact of numerous laws and regulations that apply to the
manufacture, sale, and manufacturing of nutritional supplements, and compliance with these laws and regulations, as they currently exist
or as modified in the future, on us and our suppliers;

●	the risks related to product recalls; and

●	the risks related to product liability claims and litigation
to prosecute such claims.

These forward-looking statements
involve numerous risks and uncertainties. Although we believe that our expectations expressed in these forward-looking statements are
reasonable, our expectations may later be found to be incorrect. Our actual results of operations or the results of other matters that
we anticipate could be materially different from our expectations. Important risks and factors that could cause our actual results to
be materially different from our expectations are generally set forth in “Risk Factors,” “Management’s Discussion
and Analysis of Financial Condition and Results of Operations,” “Business,” “Regulation” and other sections
included or incorporated by reference in this prospectus supplement. You should thoroughly read this prospectus supplement and the documents
incorporated herein by reference with the understanding that our actual future results may be materially different from and worse than
what we expect. We qualify all of our forward-looking statements by these cautionary statements.